Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam nanocrystal injection for postoperative pain after abdominal surgery
CTR20240002Phase 3Completed
- Sponsor
- Yangtze River Pharmaceutical Group
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of meloxicam in postoperative pain, pain, sponsored by Yangtze River Pharmaceutical Group. Started Jan 2024; status: completed.
02
Drugs
meloxicam
03
Conditions
postoperative painpain
Beyond the preview
Go deeper on CTR20240002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240002.